#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Neoplasm malignant Acute myeloid leukaemia Colitis ulcerative Colorectal cancer metastatic Obesity Prostate cancer Crohn's disease Colorectal cancer Ovarian cancer Dementia Alzheimer's type Hepatocellular carcinoma Breast cancer metastatic Dermatitis atopic Asthma Non-small cell lung cancer metastatic Malignant melanoma More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Fibrosarcoma Lennox-Gastaut syndrome Pancreatic carcinoma metastatic Hairy cell leukaemia recurrent Non-Hodgkin's lymphoma unspecified histology indolent Candida infection Cardiac failure acute Immunodeficiency common variable Angiosarcoma Leukodystrophy Mantle cell lymphoma recurrent Immune-mediated renal disorder Primary immunodeficiency syndrome Amyloidosis ROHHAD syndrome More trials…

    Learn about Rare Diseases

    Primary immunodeficiency syndrome – Life with Disease Alagille syndrome Leiomyosarcoma metastatic – Life with Disease Richter’s syndrome – Treatment Carcinoid syndrome – Treatment Atypical haemolytic uraemic syndrome – Trials in Disease Fabry’s disease Atypical teratoid/rhabdoid tumour of CNS – Trials in Disease Lennox-Gastaut syndrome – Treatment Osteosarcoma metastatic More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    Ecubectedin Bedaquiline Lenograstim Fluoxetine Paliperidone Giroctocogene Fitelparvovec Enmetazobactam JNJ-75276617 Allogeneic Faecal Microbiota Zoledronic Acid Monohydrate Methadone Hydrochloride Oxybuprocaine Retinol Acetate Fulvestrant Valoctocogene Roxaparvovec Bleomycin Human Immunoglobulin G Pirfenidone RO7288817 Ademetionine More therapies…

    Learn about Your Condition

    Primary hypercholesterolaemia Morning sickness Brain cancer metastatic Uveal melanoma Mumps Biliary tract operation BK virus infection Pemphigus Paresis Neuroendocrine carcinoma Inclusion body myositis Mesothelioma Neurofibromatosis Compulsive sexual behaviour Diabetic ketoacidosis More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden

Nutritional and Metabolic Diseases

  • Study on the Effects of Roxadustat and Placebo on Cardiovascular Risk Factors and Metabolic Syndrome in Patients

    Not recruiting

    3 1 1 1
    Investigated Diseases:
    • Metabolic syndrome
    Investigated Drugs:
    • Roxadustat
    • Placebo
    Finland

  • Study on the Effects and Safety of GLM101 for Patients with PMM2-CDG

    Not recruiting

    2 1 1
    Investigated Drugs:
    • M1P Dipotassium Salt
    • Sodium Chloride
    Belgium Czechia France Germany Italy Poland +2

  • Study on Dapiglutide for Weight Loss in Adults with Obesity

    Not recruiting

    2 1
    Investigated Diseases:
    • Obesity
    Investigated Drugs:
    • DAPIGLUTIDE
    Denmark

  • Study on Rimegepant and Capsaicin for Migraine in Lean and Obese Patients

    Not recruiting

    3 1 1 1
    Investigated Diseases:
    • Migraine
    • Obesity
    Investigated Drugs:
    • Rimegepant
    • Capsaicin
    The Netherlands

  • Study of Semaglutide and Glucagon Effects on Energy Expenditure and Glucose Levels in Healthy Volunteers

    Not recruiting

    1 1 1 1
    Investigated Diseases:
    • Obesity
    Investigated Drugs:
    • Semaglutide
    Latvia

  • Study on the Effects of EMP16 and Ispaghula Husk for Obesity in Adults

    Not recruiting

    2 1 1
    Investigated Diseases:
    • Obesity
    Investigated Drugs:
    • ACARBOSE
    • ISPAGHULA HUSK
    • Orlistat
    Sweden
Previous Page
1 … 35 36 37 38 39 … 61
Next Page

Investigational Drugs in This Location

See which drug candidates are part of clinical trials near you. Click for detailed trial information.

Medical Conditions Being Studied in This Location

Explore diseases currently included in clinical trials near you. Click to view trials and details for each condition.

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!